Statements (50)
Predicate | Object |
---|---|
gptkbp:instanceOf |
medication
|
gptkbp:approves |
gptkb:FDA
|
gptkbp:availability |
widely available
|
gptkbp:availableIn |
generic version
|
gptkbp:brand |
gptkb:Vasotec
|
gptkbp:clinicalTrials |
chronic kidney disease
hypertension management heart failure treatment diabetic nephropathy post-myocardial infarction |
gptkbp:contraindication |
pregnancy
angioedema history |
gptkbp:dosageForm |
10 mg
5 mg 20 mg 2.5 mg |
gptkbp:drugInterdiction |
true
ACE inhibitor |
gptkbp:endOfLife |
11 hours
|
gptkbp:formulation |
tablet
solution |
gptkbp:healthcare |
stay hydrated
monitor blood pressure avoid potassium supplements report any swelling |
https://www.w3.org/2000/01/rdf-schema#label |
Vasotec
|
gptkbp:interactsWith |
NSAIDs
lithium diuretics |
gptkbp:lastProduced |
1985
|
gptkbp:manufacturer |
gptkb:Merck_&_Co.
|
gptkbp:notableFeature |
gptkb:Benazepril
gptkb:Quinapril Lisinopril Ramipril |
gptkbp:nutritionalValue |
liver
|
gptkbp:offers |
varies by pharmacy
|
gptkbp:packaging |
blister pack
bottle |
gptkbp:route |
oral
|
gptkbp:sideEffect |
cough
low blood pressure high potassium levels |
gptkbp:storage |
room temperature
away from moisture away from light |
gptkbp:type |
Enalapril
|
gptkbp:usedFor |
hypertension
heart failure |
gptkbp:waterManagement |
kidneys
|